BRIEF published on 07/08/2024 at 16:20, 4 months 12 days ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
BRIEF published on 07/08/2024 at 16:20, 4 months 12 days ago APEIRON Biologics va être acquis par Ligand Pharmaceuticals pour 100 millions de dollars Acquisition Investissement Immuno-oncologie Biotechnologies QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 4 months 12 days ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 11/21/2024 at 09:00, 35 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 10 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 35 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 35 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 08:59, 35 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 35 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 20 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 25 minutes ago KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024
Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 27 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 15 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
